YUNG Therapist Sidekick | $825,000 | (Oct 4, 2024)
Rezilient Health | $10,000,000 | (Oct 4, 2024)
kapa.ai | $3,200,000 | (Oct 4, 2024)
Certified by Founder
Lodge
eGenesis, Inc.
start up
United States
- Cambridge, MA
- 04/09/2024
- Series B
- $191,000,000
eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis’ mission is to solve the global organ shortage crisis by developing a scalable alternative to allotransplantation.
eGenesis is reinvigorating the field of xenotransplantation by addressing the key virology and immunology hurdles that have prevented its advancement to date, and is developing commercially-viable products to save and improve the lives of patients who are waiting for an organ transplant.
- Industry Biotechnology Research
- Website https://egenesisbio.com/
- LinkedIn https://www.linkedin.com/company/egenesisbio/
Enara Bio | $32,500,000 | (Oct 4, 2024)
Paren | $3,000,000 | (Oct 4, 2024)
Avarra | $8,000,000 | (Oct 4, 2024)
Sober Sidekick by Empathy Health Tech | $2,800,000 | (Oct 4, 2024)
3Laws | $4,100,000 | (Oct 4, 2024)
Reducto | $8,400,000 | (Oct 4, 2024)
Integrated Biosciences, Inc. | $17,000,000 | (Oct 4, 2024)
Mstack Chemicals | $40,000,000 | (Oct 4, 2024)
FLORA (Flora Fertility) | $1,500,000 | (Oct 4, 2024)
AMAKA Studio | $2,000,000 | (Oct 4, 2024)